J., Hutchinson, C
You may be eligible if you: Have a BMI over 30, or over 27 with weight-related health concerns Struggle with appetite control or weight loss despite lifestyle changes Are not currently pregnant or breastfeeding Have not had bariatric surgery within the last 18 months Do not have a history of contraindicated conditions such as pancreatitis, medullary thyroid cancer, pancreatitis, or MEN syndrome, or certain kinds of endocrine cancers Are committed to monthly check-ins and physician-guided care *During your consultation, a medical provider will review your health history, lab work, and goals to determine your eligibility for GLP-1 treatment for weight loss
According to Malhotra, Its always been good practice to treat both the sleep apnea and the obesity in the sense that, if somebody has excess weight, rather than just giving them a CPAP, ideally treat the body weight and the sleep apneanot either/or. GLP-1 use doesnt appear to be causing patients to simply abandon their CPAP, either
Tirzepatide is a GLP-1 receptor agonist too, but it is also a GIP (glucose-dependent insulinotropic polypeptide) receptor agonist
What does the research say about naltrexone and GLP-1 combination therapy
